Comorbidity and dementia: A nationwide survey in Taiwan
Open Access
- 12 April 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (4) , e0175475
Abstract
Comorbid medical diseases are highly prevalent in the geriatric population, imposing hardship on healthcare services for demented individuals. Dementia also complicates clinical care for other co-existing medical conditions. This study investigated the comorbidities associated with dementia in the elderly population aged 65 years and over in Taiwan. We conducted a nationwide, population-based, cross-sectional survey; participants were selected by computerized random sampling from all 19 Taiwan counties between December 2011 and March 2013. After exclusion of incomplete or erroneous data, 8,456 subjects were enrolled. Of them, 6,183 were cognitively normal (control group), 1,576 had mild cognitive impairment (MCI), and 697 had dementia. We collected information about types of comorbidities (i.e., vascular risk factors, lung diseases, liver diseases, gastrointestinal diseases, and cancers), Charlson comorbidity index score, and demographic variables to compare subjects with normal cognition, MCI, and dementia. Regardless of the cognitive condition, over 60% of the individuals in each group had at least one comorbid disease. The proportion of subjects possessing at least three comorbidities was higher in those with cognitive impairment (MCI 20.9%, dementia 27.3%) than in control group (15%). Hypertension and diabetes mellitus were the most common comorbidities. The mean number of comorbidities and Charlson comorbidity index score were greater in MCI and dementia groups than in control group. Logistic regression demonstrated that the comorbidities significantly associated with MCI and dementia were cerebrovascular disease (OR 3.35, CI 2.62–4.28), cirrhosis (OR 3.29, CI 1.29–8.41), asthma (OR 1.56, CI 1.07–2.27), and diabetes mellitus (OR 1.24, CI 1.07–1.44). Multiple medical comorbid diseases are common in older adults, especially in those with cognitive impairment. Cerebrovascular disease, cirrhosis, asthma, and diabetes mellitus are important contributors to cognitive deterioration in the elderly. Efforts to lower cumulative medical burden in the geriatric population may benefit cognitive function.Keywords
Funding Information
- Ministry of Health and Welfare (DOH100-TD-M113-100001)
- National Science Council of Taiwan (NSC 101-2314-B-010)
- National Science Council of Taiwan (NSC 102-2314-B-010-051-MY2)
- Taipei-Veterans General Hospital (V104C-059)
This publication has 44 references indexed in Scilit:
- Prevalence Studies of Dementia in Mainland China, Hong Kong and Taiwan: A Systematic Review and Meta-AnalysisPLOS ONE, 2013
- Occurrence of medical co-morbidity in mild cognitive impairment: implications for generalisation of MCI researchAge and Ageing, 2011
- Epidemiology of Alzheimer diseaseNature Reviews Neurology, 2011
- Clinical Characteristics of a Nationwide Hospital-based Registry of Mild-to-Moderate Alzheimer's Disease Patients in Korea: A CREDOS (Clinical Research Center for Dementia of South Korea) StudyJournal of Korean Medical Science, 2011
- Prevalence of coexisting diseases in patients with Alzheimer's diseaseGeriatrics & Gerontology International, 2010
- Institution Type-Dependent High Prevalence of Dementia in Long-Term Care UnitsNeuroepidemiology, 2007
- Lipid metabolism in cognitive decline and dementiaBrain Research Reviews, 2006
- Cardiovascular Disease Risk Factors and Cognitive ImpairmentThe American Journal of Cardiology, 2006
- Comorbidity Profile of Dementia Patients in Primary Care: Are They Sicker?Journal of the American Geriatrics Society, 2005
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987